Access Strategy & Launch Planning

Effective access strategy starts well before launch. I work with clients to anticipate payer expectations, integrate early pricing and policy insights, and develop launch strategies that align evidence, value, and communication.
Drawing on my experience leading access strategy across multiple therapeutic areas, I help organizations prepare for the diverse and evolving needs of payers worldwide—from high-evidence European markets to faster-moving U.S. environments. My approach balances speed, risk, and credibility to ensure launches are both successful and sustainable.
Key Deliverables
- Global and regional access strategy development
- Launch access readiness assessments
- Pricing and reimbursement landscape analysis
- Payer and HTA stakeholder mapping
- Scenario and risk planning for launch
- Access playbooks and go-to-market frameworks
Connect with Nicole
20+ years in Access & Evidence | Head of Global Value & Access at top pharma | U.S. country leadership roles
